equity companies, firms? hedge funds, or private equity firms. N N NIH, Incl: R41, A A E New Rule R42, UT1, October 2017 plan UT2, R43, plan is Plan should Release (NIH) FDA, R44, U43, required for all not be submitted U44, SB1, SBIR/STTR for Phase I UB1 applications applications VA other than unless the Phase I and not phase 1 is for applying to DOE DOE Have you N N NIH, Incl: R43, Provide error if Company E New Rule received R44, U43, Company SBIR October 2017 history is Phase II Release (NIH) FDA, history is not required, if your awards provided when response to the from the response to the question, “Have Federal VA question, Have you received “ you receive SBIR Phase II SBIR Phase II awards from the Company awards from the Federal Federal is Government?” “Yes”. History
equity firms? companies, hedge funds, or private equity firms. (NIH) plan N N NIH, FDA, VA Incl: R41, R42, UT1, UT2, R43, R44, U43, U44, SB1, UB1 A plan is required for all SBIR/STTR applications other than Phase I and not applying to DOE A Plan should not be submitted for Phase I applications unless the phase 1 is for DOE E New Rule October 2017 Release (NIH) Have you received SBIR Phase II awards from the Federal Company History N N NIH, FDA, VA Incl: R43, R44, U43, Provide error if Company history is not provided when response to the question, “ Have you receive SBIR Phase II awards from the Federal Company history is required, if your response to the question, “Have you received SBIR Phase II awards from the Federal Government?” is “Yes”. E New Rule October 2017 Release
eSub-validations-draft-10-10-2017.docx